Literature DB >> 22688365

Cystic fibrosis papers of the year 2010-2011.

David Honeybourne1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22688365      PMCID： PMC3372300          DOI： 10.1258/jrsm.2012.12s006

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  21 in total

1.  Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries.

Authors:  Gita Mehta; Milan Macek; Anil Mehta
Journal:  J Cyst Fibros       Date:  2010-11-01       Impact factor: 5.482

2.  Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function.

Authors:  J Michael Collaco; Scott M Blackman; John McGready; Kathleen M Naughton; Garry R Cutting
Journal:  J Pediatr       Date:  2010-06-30       Impact factor: 4.406

Review 3.  Timing of dornase alfa inhalation for cystic fibrosis.

Authors:  Ruth Dentice; Mark Elkins
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

4.  Effects of social class, sex, and region of residence on age at death from cystic fibrosis.

Authors:  J R Britton
Journal:  BMJ       Date:  1989-02-25

5.  Long-term comparative trial of two different physiotherapy techniques; postural drainage with percussion and autogenic drainage, in the treatment of cystic fibrosis.

Authors:  Maggie McIlwaine; Lawrence T Wong; Mark Chilvers; George F Davidson
Journal:  Pediatr Pulmonol       Date:  2010-11

6.  Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.

Authors:  Martina Ulrich; Isabelle Beer; Peter Braitmaier; Michaela Dierkes; Florian Kummer; Bernhard Krismer; Ulrike Schumacher; Ute Gräpler-Mainka; Joachim Riethmüller; Peter Ø Jensen; Thomas Bjarnsholt; Niels Høiby; Gabriel Bellon; Gerd Döring
Journal:  Thorax       Date:  2010-09-29       Impact factor: 9.139

7.  Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Authors:  Don B Sanders; Rachel C L Bittner; Margaret Rosenfeld; Lucas R Hoffman; Gregory J Redding; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

8.  Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.

Authors:  Don B Sanders; Rachel C L Bittner; Margaret Rosenfeld; Gregory J Redding; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2010-10-21

9.  Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis.

Authors:  Elisabeth P Dellon; Mitchell D Shores; Katherine I Nelson; Joanne Wolfe; Terry L Noah; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2010-09-09       Impact factor: 3.612

10.  Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.

Authors:  Frank J Accurso; Steven M Rowe; J P Clancy; Michael P Boyle; Jordan M Dunitz; Peter R Durie; Scott D Sagel; Douglas B Hornick; Michael W Konstan; Scott H Donaldson; Richard B Moss; Joseph M Pilewski; Ronald C Rubenstein; Ahmet Z Uluer; Moira L Aitken; Steven D Freedman; Lynn M Rose; Nicole Mayer-Hamblett; Qunming Dong; Jiuhong Zha; Anne J Stone; Eric R Olson; Claudia L Ordoñez; Preston W Campbell; Melissa A Ashlock; Bonnie W Ramsey
Journal:  N Engl J Med       Date:  2010-11-18       Impact factor: 176.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.